Chairman
Xenon Pharmaceuticals Inc. (XENE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Simon Pimstone is recorded as Chairman at Xenon Pharmaceuticals Inc. (XENE). The proxy statement of Xenon Pharmaceuticals Inc. reports total compensation of $4,116,416 for Simon Pimstone in fiscal 2021, including a base salary of $525,511. Disclosed compensation is on record for 5 fiscal years. Simon Pimstone has spoken on 6 earnings calls across 1 company, most recently for Xenon Pharmaceuticals Inc. on August 11, 2021.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2021-01-14–present
Start not stated–2023-04-27
Last confirmed by a filing; no departure on record
Start not stated–2021-04-28
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
Chairman
2021-01-14–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Xenon Pharmaceuticals Inc. (XENE) | Executive Chair of the Board | $525,511 | $4,116,416 |
| 2020 | Xenon Pharmaceuticals Inc. (XENE) | Executive Chair of the Board | $498,117 | $2,941,911 |
| 2019 | Xenon Pharmaceuticals Inc. (XENE) | Executive Chair of the Board | $445,688 | $2,612,720 |
| 2018 | Xenon Pharmaceuticals Inc. (XENE) | Chief Executive Officer | $400,555 | $1,165,195 |
| 2017 | Xenon Pharmaceuticals Inc. (XENE) | Chief Executive Officer | $399,052 | $1,469,198 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
